Hangai-Hoger, Nanae, Amy G. Tsai -The microvascular distribution of oxygen was studied in the arterioles and venules of the awake hamster window chamber preparation to determine the contribution of vascular smooth muscle relaxation to oxygen consumption of the microvascular wall during verapamil-induced vasodilatation. Verapamil HCl delivered in a 0.1 mg/kg bolus injection followed by a continuous infusion of 0.01 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 caused significant arteriolar dilatation, increased microvascular flow and functional capillary density, and decreased arteriolar vessel wall transmural PO 2 difference. Verapamil caused tissue PO2 to increase from 25.5 Ϯ 4.1 mmHg under control condition to 32.0 Ϯ 3.7 mmHg during verapamil treatment. Total oxygen released by the microcirculation to the tissue remained the same as at baseline. Maintenance of the same level of oxygen release to the tissue, increased tissue PO 2, and decreased wall oxygen concentration gradient are compatible if vasodilatation significantly lowers vessel wall oxygen consumption, which in this model appears to constitute an important oxygenconsuming compartment. These findings show that treatment with verapamil, which increases oxygen supply through vasodilatation, may further improve tissue oxygenation by lowering oxygen consumption of the microcirculation.
vasoactivity; oxygen gradients; tissue oxygenation; microvessel metabolism THE RELEASE OF OXYGEN from blood to the tissue occurs in arterioles and capillaries. This process was first made evident by Duling and Berne (3), who measured PO 2 distribution in the microvascular network of skeletal muscle with polarographic microelectrodes and found that a substantial amount of oxygen exited the arterioles before blood arrived at the capillaries. The diffusional oxygen exit from the arterioles is driven by the magnitude of the blood-tissue oxygen concentration gradient. The development of the phosphorescence decay technique (10) enabled a quantitative measurement of these gradients. Such measurements show that, in general, these gradients are relatively large and, therefore, commensurate with the high rates of oxygen exit measured in the arterioles of the hamster window model (7) and mesentery (19) and in skeletal muscle (13) . These studies also showed that existence of such large gradients in conjunction with a large diffusional flux is possible if the tissue in which the gradient is present consumes oxygen.
The rate of oxygen consumption of the blood vessels has not been extensively studied in vivo. There is some evidence that it may be related to the tone that blood vessels maintain to regulate blood flow. According to the study of Ye et al. (23) , when the vascular beds of the rat hindlimb, kidney, intestine, and mesentery constrict and develop tone from a relaxed state, their oxygen consumption virtually doubles if blood flow is maintained constant. This study indicated that perfused blood vessels in the mesentery consumed oxygen at a rate of 115 mol⅐h Ϫ1 ⅐g blood vessel wt Ϫ1 at 25°C (4.3 ϫ 10 Ϫ2 ml O 2 ⅐min Ϫ1 ⅐g tissue wt Ϫ1 ). On constriction, oxygen consumption increased by 75%. Vasoconstriction per se lowers tissue perfusion and functional capillary density (FCD) (16) ; therefore, it is not likely that the increased oxygen consumption was due to a better perfusion of the tissue, although the authors favored that interpretation in later studies (14, 15) . Arteriolar wall oxygen consumption was found to increase significantly during treatment with vasopressin, showing that vasoconstriction is a process that increases oxygen consumption of the vessel wall (5) . The microcirculation in a tissue at rest supplies the tissue with its basal oxygen requirements; therefore, it is in a state of moderate vasoconstriction. Because further constriction from this condition increases oxygen consumption by the microvessels, we propose that inducing vasodilatation in a tissue at rest should lower arteriolar wall oxygen consumption. In the present study, we mapped the oxygen distribution in the microcirculation of the hamster chamber window preparation during administration of the Ca 2ϩ channel blocker verapamil HCl (0.1 mg/kg bolus injection followed by 0.01 mg⅐kg Ϫ1 ⅐min Ϫ1 continuous infusion) to determine whether vasodilatation lowers the arteriolar vessel wall gradient and, presumably, vessel wall oxygen consumption.
MATERIALS AND METHODS

Animal Preparation
Investigations were performed in Syrian (golden) hamsters (Charles River Laboratories, Boston, MA). Animal handling and care were provided following the procedures outlined in the Guide for the Care and Use of Laboratory Animals (National Research Council, 1996) . The study was approved by the local Animal Subjects Committee. The hamster window chamber model is widely used for microvascular studies in the unanesthetized state, and the complete surgical technique is described in detail elsewhere (2, 4) . Briefly, animals were anesthetized for chamber implantation with an injection of pentobarbital sodium (50 mg/kg ip; Nembutal, Abbott, IL). After hair removal, sutures were used to lift the dorsal skin away from the animal, and one frame of the chamber was positioned on the animal's back. A chamber consisted of two identical titanium frames with a 15-mm circular window. With the aid of backlighting and a stereomicroscope, one side of the skinfold was removed following the outline of the window until only a thin layer of retractor muscle and the intact subcutaneous skin of the opposing side remained. Saline and then a cover glass were placed on the exposed skin held in place by the other frame of the chamber. The intact skin of the other side was exposed to the ambient environment. The animal was allowed at least 2 days for recovery; then its chamber was assessed under the microscope for any signs of edema, bleeding, or unusual neovascularization. Barring these complications, the animal was anesthetized again with pentobarbital sodium. Arterial and venous catheters (PE-50) were implanted in the carotid artery and jugular vein. The catheters were filled with a heparinized saline solution (30 IU/ml) to ensure their patency at the time of the experiment. Catheters were tunneled under the skin and exteriorized at the dorsal side of the neck, where they were attached to the chamber frame with tape. The experiment was performed after at least 24 h but within 48 h of catheter implantation.
Inclusion Criteria
Animals were suitable for the experiments if their systemic parameters were within normal range: 1) heart rate (HR) Ͼ320 beats/min, 2) mean systemic blood pressure (MAP) Ͼ80 mmHg, 3) systemic hematocrit (Hct) Ͼ45%, and 4) systemic arterial PO 2 (PaO 2 ) Ͼ50 mmHg. The microvasculature of the chamber tissue was examined under low (ϫ150) and high (ϫ650) magnification for edema and bleeding. Animals were excluded from the study when these signs of trauma were observed.
Systemic Parameters
MAP was tracked continuously over the entire experimental period, and HR was determined from the pressure trace (Spectramed Pressure Transducer, Biopac, Santa Barbara, CA). Systemic Hct was measured from centrifuged arterial blood samples taken in heparinized capillary tubes (Readacrit Centrifuge, Clay Adams, Division of Becton and Dickinson, Parsippany, NJ).
Blood Chemistry
Arterial blood was sampled from the carotid artery catheter into heparinized capillary tubes and immediately analyzed for PO2, PCO2, and pH at 37°C with a pH-blood gas analyzer (model 248, Bayer, Tarrytown, NY). Hemoglobin concentration was measured using a hand-held photometer (B-Hemoglobin, Hemocue).
Microhemodynamic Parameters
Microhemodynamics. Arteriolar and venular blood flow velocities were measured online by using the photodiode cross-correlation method (8) (Photo Diode/Velocity Tracker, model 102B, Vista Electronics, San Diego, CA). The measured centerline velocity was corrected according to vessel size to obtain the mean RBC velocity (V) (12) . The video image-shearing method was used to measure vessel diameter (D) (9) . Blood flow (Q ) was calculated as follows:
2 . Changes in arteriolar and venular diameter from baseline were used as indicators of a change in vascular tone.
Arterioles and venules. Microvessels were classified according to their position in the microvascular network (11) . Arterioles were grouped into small arteries (A 0), large feeding arterioles (A1), small arcading arterioles (A2), transverse arterioles (A3), and terminal arterioles (A4). Veins and venules were classified as small veins (V0), large venules (Vl), and small collecting venules (Vc). When arterioles exhibited vasomotion, the diameter was measured for 1 min and averaged over this interval. Detailed mappings were made of the chamber vasculature, so that the same vessels were studied throughout the experiment.
FCD. Capillaries were considered functional if RBCs transit through the capillary segments during a 45-s period. FCD was tabulated from the capillary lengths with RBC transit in an area comprising 10 successive microscopic fields (420 ϫ 320 m 2 ). FCD (cm Ϫ1 ) is the total length of RBC-perfused capillaries divided by the area of the microscopic field of view (18) .
Microvascular PO2 Distribution
PO2 was measured using the Pd-phosphorescence quenching method developed by Wilson (22) , which was implemented for microcirculatory studies according to the description of Kerger et al. (10) . This noninvasive method is based on the oxygen-dependent quenching of phosphorescence emitted by albumin-bound metalloporphyrin complex after pulsed light excitation, where rate of decay of the light-excited phosphorescence is inversely proportional to PO 2 according to the Stern-Volmer equation (21) . The Pd-phosphorescence quenching method has been used in this preparation for intravascular and extravascular PO 2 measurements, as albumin exchange between plasma and tissue allows for sufficient concentrations of albumin-bound dye within the interstitium to achieve an adequate signal-to-noise ratio (1, 19) . Animals received a slow intravenous injection of Pd-meso-tetra(4-carboxyphenyl)porphyrin (Porphyrin Products, Logan, UT; 15 mg/kg body wt at 10.1 mg/ml). The dye was allowed to circulate for 10 min before oxygen measurements.
For intravascular measurements, an optical rectangular window (ϳ5 ϫ 40 m) was placed longitudinally within the vessel of interest, with the longest side of the rectangle positioned parallel to the vessel wall. Tissue PO 2 was measured within intercapillary spaces in regions without large vessels with an optical window size of 6 ϫ 6 m. The decay curves were analyzed offline by means of a standard singleexponential least-squares numerical fitting technique, and the resultant time constants were applied to the Stern-Volmer equation (21) to calculate PO 2 with use of parameters corrected for this animal model. The phosphorescence decay due to quenching at a specific PO2 yields a single decay constant, and in vitro calibration has been demonstrated to be valid for in vivo measurements.
Oxygen Saturation Curve for Hamster Blood
Oxygen saturation of hemoglobin was investigated by deoxygenation of oxygen-equilibrated oxyhemoglobin in a Hemox buffer (pH 7.4) at 37.6°C using a Hemox analyzer (TCS Scientific, New Hope, PA), which measures PO2 with a Clark-type O2 electrode (Yellow Springs Instrument, Yellow Springs, OH) and simultaneously calculates the hemoglobin saturation via a dual-wavelength spectrophotometer. PO 2 at which hemoglobin is half-saturated (P50) was obtained directly from the oxygen equilibrium curves. Oxygen equilibrium curves for hamster RBCs were determined from freshly collected blood.
Experimental Design
The unanesthetized animal was placed in a restraining tube, which was attached to the stage of an inverted microscope (model IMT-2, Olympus, New Hyde Park, NY) equipped with a ϫ20 objective (Olympus SPlan, NA ϭ 0.46). The tissue image was projected onto a charge-coupled device camera (model 4815-2000, COHU, San Diego, CA) connected to a video cassette recorder (Panasonic AG-7355, Matsushita Electric Industries, Osaka, Japan) and viewed on a monitor (model PVM-1271Q, Sony, Tokyo, Japan). Sites of investigation were chosen on the basis of their visual acuity and vessel type within the network. The same sites of measurement were followed throughout the experiments, so that comparisons could be made directly with baseline levels.
Baseline systemic parameters, blood gas analysis, vascular diameter, RBC velocity, and FCD measurements commenced 30 min after the animal had become accustomed to the restraining tube. The Pd-porphyrin dye was injected intravenously over a 1-min period and allowed 10 min to distribute. Intravascular PO 2 in the vessels chosen for study was measured along with vessel diameter and RBC velocity. Microvascular characterization and intravascular PO 2 measurements were followed by interstitial tissue PO2 measurements. Blood gas analysis was repeated to ensure that stable oxygen levels were maintained during the observation period.
From a pilot study of the vascular diameter and blood pressure response, it was determined that the chosen dosage was able to sustain a moderate level of arteriolar dilatation (15%) without a substantial decrease in blood pressure for Ն2-3 h. After 1 h of sustained dilatation, FCD was assessed, and capillary fields were recorded for 1 min for later offline analysis of RBC velocity. Next, the phosphorescence dye was infused into the venous catheter and allowed to circulate, and then intravascular and perivascular PO 2 of arterioles and venules was measured. Flow and diameter were also measured online in these larger vessels. MAP and HR were monitored throughout the experiment.
Control data on microvascular PO 2 distribution were obtained from 5 animals.
Data Analysis
The value presented for each parameter of microvascular hemodynamics and oxygenation (vessel diameter, flow velocity, flow, blood PO 2, and FCD) is the average for all the animals in the study (n ϭ 9). In the case of systemic parameters, each animal in the study is characterized by a value that is then averaged for the population of this study (n ϭ 9). Results are presented as means Ϯ SD unless otherwise noted. Data are presented as absolute values and ratios relative to baseline values: a ratio of 1.0 would signify no change from baseline, whereas lower and higher numbers are indicative of changes from baseline (i.e., 1.5 would mean a 50% increase from baseline levels and 0.5 would mean a 50% decrease in baseline levels). All measurements were compared with their levels at baseline. Changes are considered statistically significant if P Յ 0.05.
RESULTS
A total of five animals (58 -72 g, mean 66 g) were used in the control group, and nine animals (47-76 g, mean 61 g) were treated with verapamil. Each study was completed 3 h from the start of the experiment.
Systemic Parameters
Systemic parameters at baseline and after verapamil injection are shown in Table 1 . Baseline MAP of 121 Ϯ 7 mmHg was reduced to 116 Ϯ 9 mmHg at 1 h after verapamil treatment (P Ͻ 0.05). HR was 413 Ϯ 39 beats/min at baseline and 393 Ϯ 36 beats/min 1 h after verapamil treatment, a change that was not statistically significant.
Arterial blood gases were investigated at baseline and 1 h after verapamil injection. At baseline, Pa O 2 was 59.2 Ϯ 4.4 mmHg, arterial PCO 2 (Pa CO 2 ) was 55.5 Ϯ 5.7 mmHg, pH was 7.38 Ϯ 0.03, and base excess was 6.6 Ϯ 1.7. At 1 h after verapamil injection, Pa O 2 was 65.2 Ϯ 9.2 mmHg, Pa CO 2 was 54.7 Ϯ 6.9 mmHg, pH was 7.37 Ϯ 0.02, and base excess was 5.6 Ϯ 4.0. After verapamil treatment, Pa O 2 was significantly higher than baseline (P Ͻ 0.05), whereas Pa CO 2 , pH, and base excess were not significantly changed.
Microvascular Hemodynamics
Arteriolar diameter increased to 1.20 Ϯ 0.17 (n ϭ 100, P Ͻ 0.001) and venular diameter was 1.11 Ϯ 0.19 (n ϭ 93, P Ͻ 0.001) after verapamil treatment (Fig. 1A) . Arterioles dilated more than venules, but the difference was not significant; however, all changes were significantly greater than baseline. A 3 vessels showed the largest dilatation.
RBC velocity significantly increased (P Ͻ 0.001) from baseline to 1.28 Ϯ 0.45 in arterioles and 1.30 Ϯ 0.47 in venules (Fig. 1B) . In each order of vessels, RBC velocity was increased from baseline.
Calculated flows increased to 2.00 Ϯ 1.38 (P Ͻ 0.005) of baseline in arterioles and 1.56 Ϯ 0.65 (P Ͻ 0.005) in venules ( 
FCD
FCD in the verapamil-treated group was increased 1.05 Ϯ 0.02 (P Ͻ 0.005), a change that was significant compared with baseline.
Oxygen Distribution in the Microvascular Network
Oxygen distribution in the different vessel orders in the control group is shown in Fig. 2 . Intravascular and perivascular PO 2 were measured in arterioles and venules and in the surrounding tissue. Intravascular PO 2 was 56.8 Ϯ 3.2 mmHg in A 0 (n ϭ 17), 51.8 Ϯ 5.8 mmHg in A 1 (n ϭ 12), 44.3 Ϯ 3.8 mmHg in A 2 (n ϭ 11), 39.9 Ϯ 4.7 mmHg in A 3 (n ϭ 11), 37.2 Ϯ 3.2 mmHg in A 4 (n ϭ 17), 31.0 Ϯ 3.6 mmHg in V c (n ϭ 28), 35.1 Ϯ 2.7 mmHg in V l (n ϭ 16), 41.1 Ϯ 3.3 mmHg in V 0 (n ϭ 12), and 25.5 Ϯ 4.1 mmHg in the tissue (n ϭ 46). Perivascular PO 2 was 36.9 Ϯ 6.4 mmHg in A 0 , 36.7 Ϯ 7. Values are means Ϯ SD; n ϭ 9. Hct, systemic hematocrit; P50, PO2 at which Hb is half-saturated; MAP, mean arterial blood pressure; HR, heart rate; PaO 2 , arterial PO2; PaCO 2 , arterial PCO 2 ; pHa, arterial pH; BE, base excess. *P Ͻ 0.05 vs. baseline. 38.7 Ϯ 7.8 mmHg in A 0 , 37.9 Ϯ 6.3 mmHg in A 1 , 33.6 Ϯ 5.6 mmHg in A 2 , 32.5 Ϯ 2.5 mmHg in A 3 , 32.1 Ϯ 2.4 mmHg in A 4 , 29.6 Ϯ 4.9 mmHg in V c , 30.5 Ϯ 4.5 mmHg in V l , and 30.9 Ϯ 3.6 mmHg in V 0 . Intravascular PO 2 was significantly lower in A 0 and A 1 arterioles and higher in the tissue and V c venules after verapamil injection. Perivascular PO 2 was significantly higher in A 4 arterioles, tissues, and V c and V l venules.
The oxygen gradient at the vascular wall was estimated from the difference between PO 2 measured in blood at a position adjacent to the blood vessel wall interface and PO 2 measured in the tissue in the immediate vicinity of the vessel wall. This difference in PO 2 was not normalized to a length scale; therefore, the quantity reported is not actually a gradient and is referred to as the vessel wall PO 2 difference (Fig. 2) . The wall PO 2 difference was 19.9 Ϯ 5. Table 2 .
Tissue PO 2 was significantly different (P Ͻ 0.001) between control (25.5 Ϯ 4.1 mmHg) and verapamil (32.0 Ϯ 3.7 mmHg) groups.
Oxygen release to the microcirculation was calculated as follows
where Hb RBC is the amount of hemoglobin, ⌬ a-v % is the difference in O 2 saturation between arterioles and venules given by O 2 dissociation curve, and Q is the average flow through the paired arteriolar and venular vessels. Results are given in Table 2 , where flow is normalized relative to control.
DISCUSSION
The principal finding of this study is that a continuous intravenous infusion of a clinically relevant dose of verapamil increased the rate of oxygen delivery by the arteriolar vessels, maintained constant or decreased the rate of oxygen release to the microcirculation, and increased tissue PO 2 . Administration of verapamil increased arteriolar diameter and microvascular flow, significantly increased FCD, and substantially lowered arteriolar vessel wall-transmural PO 2 gradient. The latter effect (5) . Arteriolar (Art) PO2 distribution is similar for the 3 conditions. PO2 difference across the vessel wall is the difference between tissue PO2 on the blood side of the blood-tissue interface and that on the tissue side. *Significantly different from control (P Ͻ 0.05). We assume that vessels with outer wall PO2 that is not statistically different from tissue PO2 on the average do not release oxygen to the tissue. Ven, venular. 0 -4 refers to A0-A4 (see Fig. 1) ; C, L, and 0 refer to Vc, Vl, and V0 (see Fig. 1) ; T, tissue.
may be a factor in the significantly higher tissue PO 2 in the vasodilatation condition. Verapamil, an L-type Ca 2ϩ blocker, did not effect MAP, HR, and other systemic parameters in this study; therefore, the observed change in tissue PO 2 was due to direct effects of verapamil in the microcirculation. Verapamil had an effect on the oxygen dissociation curve of hemoglobin, causing a slight but significant decrease of P 50 from 32 to 30 mmHg.
The intravascular distribution pattern of PO 2 in the control group (Fig. 2) is the same as that found in previous studies of this tissue (6) . The pattern of oxygen distribution was not significantly different after verapamil treatment, although there was a tendency for intravascular PO 2 to be somewhat lower. Tissue PO 2 was 32.0 Ϯ 3.7 mmHg, which was significantly elevated relative to control (25.5 Ϯ 4.1 mmHg). The same elevated level was found in a previous study on the effects of hyperoxia due to 100% inspired oxygen, where tissue PO 2 was 31.9 Ϯ 0.9 mmHg (17) . In the case of hyperoxia, oxygen delivery remained constant compared with normoxia, but intravascular arteriolar and venular PO 2 values were higher, and tissue equilibrated with the higher values of venular PO 2 .
In the present study, oxygen release to the tissue was approximately the same for control and verapamil treatment when computed between A 1 and V 1 vessels and lower vessel order pairings (Table 2) . Oxygen release between A 0 and V 0 vessels after verapamil treatment was about double that in the control condition; however, these vessels are rather large (87.2-165.3 m diameter for A 0 and 165.8 -383.6 m diameter for V 0 ), and their oxygen content may not reflect events of the tissue in the window chamber, where microvascular parameters were measured.
The PO 2 difference across the microvascular wall was significantly decreased relative to control and arginine vasopressin. In the studies of Tsai et al. (19) , Shibata et al. (13) , and Friesenecker et al. (5) , this difference in PO 2 is ϳ18 mmHg in A 1 arterioles in control conditions, which is similar to the value found in the present study (ϳ16 mmHg). As a consequence of the cylindrical geometry, it can be shown that the minimum PO 2 difference in A 1 arterioles is ϳ12 mmHg, assuming that the vessel wall tissue consumes oxygen at the same rate as most tissues or ϳ10 Ϫ2 ml O 2 ⅐min Ϫ1 ⅐g tissue Ϫ1 (20) . This theoretical lower limit appears to be reached in the present study, because in A 1 vessels the PO 2 difference is ϳ10 mmHg.
Subtraction of the vessel wall PO 2 difference from the intraluminally measured PO 2 shows the PO 2 of the outer microvessel wall, which is the oxygen source "seen" by the tissue, which governs the exchange of oxygen between the microvessels and the tissue. In control baseline conditions, the PO 2 of the outer surface of the vessel wall of arterioles and venules is always greater than tissue PO 2 (Fig. 2) , indicating that all microvessels release oxygen to the tissue. Conversely, verapamil treatment causes the PO 2 of the outer vessel wall of arterioles from A 2 to V 0 venules to not be significantly different from tissue PO 2 . Therefore, these vessels are in oxygen equilibrium with the tissue, indicating that tissue is primarily oxygenated by the oxygen released from the A 0 and A 1 vessels, whereas the oxygen released from the remainder of the microvessels is used by the microvessels per se. The effects found using the same protocol while the tissue was treated with the vasoconstrictor arginine vasopressin (5) are also shown in Fig. 2 .
The analysis is based on the concept that only the vessels with a greater PO 2 on the outer surface than in the tissue can supply oxygen to the tissue. This is a statistical consideration based on averages and, not necessarily, restricted to A 0 and A 1 vessels. Local variations will cause some of the vessels of most vessel orders to participate in this process. An important caveat is that oxygen release to the tissue cannot be estimated solely from the analysis of the changes of blood oxygen saturation, because blood oxygenates the tissue through the vessel wall, which extracts a portion of oxygen in relation to its tone. It is not possible to establish the exact proportion of vessel wall oxygen consumption vs. tissue oxygen consumption of the different conditions of vasoconstriction and vasorelaxation; however, this work and related studies show that vasoconstriction and vasorelaxation have an influence on tissue oxygenation, independently of the associated changes in local blood flow. An unknown in these calculations is the exact oxygen saturation at the venous exit from the microcirculation, a parameter determined from the oxygen saturation curve measured in the Hemox analyzer that is significantly changed by the Bohr effect. This effect, however, should be the same for normal baseline conditions and verapamil treatment, because there were no changes in pH.
Lowering of the vessel wall gradient could also be the consequence of the increase in the diffusion constant for oxygen across the vessel wall caused by verapamil; however, there is no mechanism to account for this phenomenon.
In conclusion, verapamil lowers the PO 2 difference across the vessel wall (also referred to as the vessel wall gradient) in the microcirculation. This phenomenon leads to the increase in tissue PO 2 to the level obtained with 100% inspired oxygen as more oxygen is available to the tissue and less oxygen appears to be consumed in the vessel wall. Calculation of the oxygen released to the tissue and the microcirculation in control and during verapamil treatment shows that this parameter remains unchanged. In control conditions, all vessels in the microcirculation deliver oxygen to the microvessels and the tissue; during verapamil treatment, the outside of the vessel wall surface of microvessels from A 2 to V 0 is in equilibrium with the tissue. The source of oxygen to the tissue is the blood-blood vessel combination taken as a unit. Therefore, most of the oxygen is delivered to the tissue during verapamil treatment by A 0 and A 1 vessels, and this oxygen delivery is sufficient to elevate tissue PO 2 . The present findings support the hypothesis Relative values resulting from application of Eq. 1 are shown. *Flow is average value of arteriolar and venular flow at the corresponding level of branching relative to control ϭ 1.00. ⌬sat ϭ difference in oxygen saturation of RBC hemoglobin between the vessel orders indicated. A0, small artery; A1, larger feeding arteriole; A2, small feeding arteriole; A3, transverse arteriole; A4, terminal arteriole; V0 small vein; V1, large venule; Vc, small collecting venule.
that the vessel wall consumes a significant amount of oxygen and that this process is modulated by vasodilatation as well as vasoconstriction, as shown previously.
